1. Home
  2. FINW vs CCCC Comparison

FINW vs CCCC Comparison

Compare FINW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinWise Bancorp

FINW

FinWise Bancorp

N/A

Current Price

$18.05

Market Cap

242.1M

Sector

Finance

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.73

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINW
CCCC
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.1M
240.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FINW
CCCC
Price
$18.05
$2.73
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$21.67
$8.50
AVG Volume (30 Days)
11.8K
1.4M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.05
N/A
Revenue
$80,198,000.00
$30,108,000.00
Revenue This Year
$72.14
N/A
Revenue Next Year
$47.30
N/A
P/E Ratio
$17.17
N/A
Revenue Growth
14.76
N/A
52 Week Low
$13.49
$1.09
52 Week High
$22.49
$5.10

Technical Indicators

Market Signals
Indicator
FINW
CCCC
Relative Strength Index (RSI) 43.37 62.08
Support Level $17.65 $2.29
Resistance Level $18.21 $2.63
Average True Range (ATR) 0.62 0.15
MACD -0.04 0.03
Stochastic Oscillator 14.25 92.41

Price Performance

Historical Comparison
FINW
CCCC

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: